Study to Evaluate Safety, Tolerability and Drug Levels of BMS-986435/MYK-224 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)
Clinical trial NCT06122779 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06122779
- Sponsor
- Bristol-Myers Squibb
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-07
- Primary completion
- 2026-12-14
- Enrollment
- 227
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.